183306-87-8

Upstream product

• 873-62-1 m-cyanophenol 
• 16297-14-6 2,3,5,6-tetrafluoro-4-methylpyridine 

Downstream Products

• 183307-71-3 3-[(6-(3-aminophenoxy)-3,5-difluoro-4-methylpyridin-2-yl)oxy]benzonitrile 
• 183306-81-2 3,3'-<3,5-difluoro-4-methyl-2,6-pyridinediylbis(oxy)>bis(benzonitrile) 
• 183307-34-8 3-[(6-(3-cyanophenoxy)-3,5-difluoro-4-methylpyridin-2-yl)oxy]-N,N-dimethylbenzamide 
• 183307-22-4 3-[(3,5-difluoro-4-methyl-6-(3-(morpholin-4-yl)phenoxy)pyridin-2-yl)oxy]benzonitrile 
• 183307-66-6 3-[3,5-difluoro-4-methyl-6-(pyridin-3-yloxy)pyridin-2-yloxy]benzonitrile 
• 183307-63-3 3,4'-[2,6-pyridinediylbis(oxy)]bis(benzonitrile) 
• 199789-01-0 4-[(6-(3-cyanophenoxy)-3,5-difluoro-4-methylpyridin-2-yl)oxy]-α-hydroxybenzeneacetic acid 
• 183307-67-7 3-[(3,5-difluoro-4-methyl-6-phenoxypyridin-2-yl)oxy]benzonitrile 

Relevant academic research and scientific papers

Benzamidine derivatives and their use as anti-coagulants

This invention is directed to benzamidine derivatives which are useful as anti-coagulants. This invention is also directed to pharmaceutical compositions containing the compounds of the invention, and methods of using the compounds to treat disease-states characterized by thrombotic activity.

Benzamidine derivatives and their use as anti-coagulants

This invention is directed to benzamidine derivatives which are useful as anti-coagulants. This invention is also directed to pharmaceutical compositions containing the compounds of the invention, and methods of using the compounds to treat disease-states characterized by thrombotic activity.